Express Pharma

MARCH 20, 2025

Over the past decade and more, Indias pharmaceutical sector has become the worlds largest supplier of generic medicines, with exports growing faster than the global average. The industry is at a tipping point, however: the Indian and global landscapes are shifting.

Generic Medicine 66

Generic Medicine Dosage Packaging 66

Quality Matters

APRIL 18, 2024

For separate external shipping containers, USP has also reduced the need for plastic wrap and is evaluating smaller container sizes and biodegradable packaging materials, as well as a more easily recyclable alternative to EPS for cold-chain applications. In addition, they are more compact and 44% lighter than previous versions, on average.

Pharmaceutical Manufacturing 59

Pharmaceutical Manufacturing Packaging Generic Medicine 59

Quality Matters

APRIL 26, 2023

Quality standards and related tools – supported by appropriate regulatory capability and enforcement – can help promote quality across the pharmaceutical product lifecycle, from the sourcing of active and inactive ingredients to packaging, labeling, distribution, and point-of-care administration.

Prescription Filling 52

Prescription Filling Generic Medicine Packaging Labelling 52

European Pharmaceutical Review

APRIL 25, 2024

Research on the global pharmaceutical parenteral packaging market by InsightAce Analytic Pvt. Main drivers for the market were reported to be rising popularity of generics together with blockbuster and other small-molecule drugs going off-patent globally. has predicted that the sector will value $18.85 billion by 2031. Catalent Inc.

Packaging 98

Packaging Generic Medicine Diabetes Vaccines 98

Express Pharma

NOVEMBER 15, 2024

Integrating ESG considerations into core pharma operations India, known as the “Pharmacy of the World,” produces over 20 per cent of the global supply of generic medicines and plays a vital role in vaccine production, as per the Investindia.gov.in It meets the healthcare needs of over 1.4

Packaging 102

Packaging Generic Medicine Pharmaceutical Manufacturing Vaccines 102

pharmaphorum

MAY 27, 2022

Liam Johnstone has six years of toxicology experience working across regulators in the UK, developing expertise in medicine, consumer product and agrochemical safety whilst working at the MHRA, OPSS and HSE, respectively. As a Non-Clinical Assessor at MHRA he assessed non-clinical data packages for new and generic medicines.

Packaging 80

Packaging Generic Medicine Communication Hospitals 80

STAT

OCTOBER 10, 2023

The big blow to Sunovion, he said, was the loss of patent protection for Latuda, its best-selling schizophrenia drug, which led to competition from cheaper generic medicines. “The severance package that I received from Sunovion was very generous and will tide me over until December,” he said. Absolutely.”

Vaccines 331

Vaccines Generic Medicine Drug Development Packaging 331

Express Pharma

APRIL 25, 2025

Known as the Pharmacy of the World, India supplies almost 20 per cent of global generic medicines. Paying attention to details at every step, from labeling, packaging, and storage to transportation, ensures a supply chain where quality and standards are maintained. per cent by value.

Packaging 59

Packaging Generic Medicine Vaccines Labelling 59

Quality Matters

APRIL 20, 2023

Quality across the product lifecycle The role of standards goes far beyond the drug manufacturing process – from the sourcing of raw materials to packaging, labeling, distribution, and point-of-care administration – to help ensure quality across the pharmaceutical product lifecycle.

Biosimilars 52

Biosimilars Labelling Vaccines Generic Medicine 52

Quality Matters

OCTOBER 13, 2021

With this extensive system in place, patients can trust that medicines with the same name will be consistent in quality no matter who manufactures it or where in the world it is made. Since manufacturers know the precise quality specifications, standards help make the approval process for generic medicines more efficient.

Pharmaceutical Manufacturing 52

Pharmaceutical Manufacturing Adverse Reactions Prescription Filling Compounding 52

pharmaphorum

MAY 26, 2022

Liam Johnstone has six years of toxicology experience working across regulators in the UK, developing expertise in medicine, consumer product and agrochemical safety whilst working at the MHRA, OPSS and HSE, respectively. As a Non-Clinical Assessor at MHRA he assessed non-clinical data packages for new and generic medicines.

Packaging 143

Packaging Vaccines Generic Medicine Compounding 143